Growth patterns in patients with congenital adrenal hyperplasia analyzed by the QEPS growth model
-
By
-
Ruta Navardauskaite
-
Aimon Niklasson
-
Andreas F. M. Nierop
-
Aldina Pivodic
-
Rasa Verkauskiene
-
Anton Holmgren
-
June 5, 2026
-
Clinical Scorecard: Assessment of Growth Trends in Congenital Adrenal Hyperplasia Patients Utilizing the QEPS Growth Model
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | |
| Target Population | Patients with congenital adrenal hyperplasia, specifically those with salt wasting and simple virilizing forms (source needed). |
| Care Setting | |
Key Highlights
- Remove unsupported claims about CAH patients not achieving target height.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
- G
- r
- o
- w
- t
- h
-
- p
- a
- t
- t
- e
- r
- n
- s
-
- s
- h
- o
- u
- l
- d
-
- b
- e
-
- m
- o
- n
- i
- t
- o
- r
- e
- d
-
- u
- s
- i
- n
- g
-
- t
- h
- e
-
- Q
- E
- P
- S
-
- m
- o
- d
- e
- l
-
- (
- s
- o
- u
- r
- c
- e
-
- n
- e
- e
- d
- e
- d
- )
- .
Risks
Patient & Prescribing Data
25 patients (13 girls) with CAH, subtyped into salt wasting and simple virilizing.
Life-long glucocorticoid treatment is necessary to correct cortisol deficiency and prevent androgen overproduction.
Clinical Best Practices
- Remove unsupported phrases regarding optimizing growth outcomes.
Related Resources & Content
